Literature DB >> 33351862

IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation.

Jana Meiners1, Martina Reitz1, Nikolas Rüdiger1, Jan-Eric Turner2, Lennart Heepmann1, Lena Rudolf1, Wiebke Hartmann1, Henry J McSorley3, Minka Breloer1,4.   

Abstract

Parasitic helminths are sensed by the immune system via tissue-derived alarmins that promote the initiation of the appropriate type 2 immune responses. Here we establish the nuclear alarmin cytokine IL-33 as a non-redundant trigger of specifically IL-9-driven and mast cell-mediated immunity to the intestinal parasite Strongyloides ratti. Blockade of endogenous IL-33 using a helminth-derived IL-33 inhibitor elevated intestinal parasite burdens in the context of reduced mast cell activation while stabilization of endogenous IL-33 or application of recombinant IL-33 reciprocally reduced intestinal parasite burdens and increased mast cell activation. Using gene-deficient mice, we show that application of IL-33 triggered rapid mast cell-mediated expulsion of parasites directly in the intestine, independent of the adaptive immune system, basophils, eosinophils or Gr-1+ cells but dependent on functional IL-9 receptor and innate lymphoid cells (ILC). Thereby we connect the described axis of IL-33-mediated ILC2 expansion to the rapid initiation of IL-9-mediated and mast cell-driven intestinal anti-helminth immunity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33351862      PMCID: PMC7787685          DOI: 10.1371/journal.ppat.1009121

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  50 in total

1.  Strongyloides ratti infection induces transient nematode-specific Th2 response and reciprocal suppression of IFN-gamma production in mice.

Authors:  M-L Eschbach; U Klemm; J Kolbaum; B Blankenhaus; N Brattig; M Breloer
Journal:  Parasite Immunol       Date:  2010-05       Impact factor: 2.280

Review 2.  Strongyloides infection in rodents: immune response and immune regulation.

Authors:  Minka Breloer; David Abraham
Journal:  Parasitology       Date:  2016-02-24       Impact factor: 3.234

Review 3.  The biology of Strongyloides spp.

Authors:  Mark E Viney; James B Lok
Journal:  WormBook       Date:  2015-07-16

4.  Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection.

Authors:  M Reitz; M-L Brunn; H-R Rodewald; T B Feyerabend; A Roers; A Dudeck; D Voehringer; F Jönsson; A A Kühl; M Breloer
Journal:  Mucosal Immunol       Date:  2016-07-06       Impact factor: 7.313

5.  IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms.

Authors:  Li-Yin Hung; Ian P Lewkowich; Lucas A Dawson; Jordan Downey; Yanfen Yang; Dirk E Smith; De'Broski R Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

6.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

Review 7.  Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.

Authors:  Corinne Cayrol; Jean-Philippe Girard
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

8.  An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation.

Authors:  Christoph Wilhelm; Keiji Hirota; Benjamin Stieglitz; Jacques Van Snick; Mauro Tolaini; Katharina Lahl; Tim Sparwasser; Helena Helmby; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-10-09       Impact factor: 25.606

9.  Extracellular Vesicles from a Helminth Parasite Suppress Macrophage Activation and Constitute an Effective Vaccine for Protective Immunity.

Authors:  Gillian Coakley; Jana L McCaskill; Jessica G Borger; Fabio Simbari; Elaine Robertson; Marissa Millar; Yvonne Harcus; Henry J McSorley; Rick M Maizels; Amy H Buck
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

10.  Interleukin-9 promotes early mast cell-mediated expulsion of Strongyloides ratti but is dispensable for generation of protective memory.

Authors:  Martina Reitz; Wiebke Hartmann; Nikolas Rüdiger; Zane Orinska; Marie-Luise Brunn; Minka Breloer
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

View more
  7 in total

Review 1.  "Every cell is an immune cell; contributions of non-hematopoietic cells to anti-helminth immunity".

Authors:  Juan M Inclan-Rico; Heather L Rossi; De'Broski R Herbert
Journal:  Mucosal Immunol       Date:  2022-05-10       Impact factor: 7.313

2.  ILC2s Control Microfilaremia During Litomosoides sigmodontis Infection in Rag2-/- Mice.

Authors:  Julia J Reichwald; Frederic Risch; Anna-Lena Neumann; Stefan J Frohberger; Johanna F Scheunemann; Benjamin Lenz; Alexandra Ehrens; Wiebke Strutz; Beatrix Schumak; Achim Hoerauf; Marc P Hübner
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

3.  Interleukin-33 deficiency prevents biliary injuries and repairments caused by Clonorchis sinensis via restraining type 2 cytokines.

Authors:  Chao Yan; Na Xu; Man Liu; Zhihua Jiang; Jing Wu; Stephane Koda; Yu Chen; Beibei Zhang; Qian Yu; Yin-Hai Xu; Jian-Lin Wu; Kui-Yang Zheng
Journal:  Parasit Vectors       Date:  2022-10-22       Impact factor: 4.047

4.  A crosstalk between type 2 innate lymphoid cells and alternative macrophages in lung development and lung diseases (Review).

Authors:  Lan-Lan Mi; Yue Zhu; Hong-Yan Lu
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

5.  Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells via IL-33/ST2 Signaling.

Authors:  Fan Deng; Jing-Juan Hu; Xiao Yang; Qi-Shun Sun; Ze-Bin Lin; Bing-Cheng Zhao; Zhi-Wen Yao; Si-Dan Luo; Ze-Ling Chen; Ying Liu; Zheng-Zheng Yan; Cai Li; Wei-Feng Liu; Ke-Xuan Liu
Journal:  Front Immunol       Date:  2021-09-28       Impact factor: 7.561

6.  The absence of IL-9 reduces allergic airway inflammation by reducing ILC2, Th2 and mast cells in murine model of asthma.

Authors:  Yan Li; Feng Lan; Yiran Yang; Yingjie Xu; Yalin Chen; Xiaofeng Qin; Zhe Lv; Wei Wang; Sun Ying; Luo Zhang
Journal:  BMC Pulm Med       Date:  2022-05-06       Impact factor: 3.320

Review 7.  The role of human mast cells in allergy and asthma.

Authors:  Ghalya H Banafea; Sherin Bakhashab; Huda F Alshaibi; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.